Browse diseases

…low body weight, AAT deficiency, inhaled corticosteroid use and cancer.…

…ty loci by genome-wide association studies (GWAS), considerable chronic obstructive pulmonary disease (COPD) heritability remains unexplained.Aim To identify interac…

…ted.Interpretation In a real-world clinical practice setting of COPD treatment, initiating therapy with LABA-ICS inhalers may be mor…

…pective study, higher ambient PM 2.5 was associated with higher COPD acute exacerbation (AE) rates, and greater use of triple therap…

…chronic obstructive pulmonary disease.Conclusions Patients with pericardial disease have a low in-hospital mortality of about 1% if this was the pr…

…0.84 years, 3759 participants with asthma at baseline developed COPD. For an IQR increase in PM 2.5 and NO2, the HR for developing C…

…which is now very common, increases the risk of developing CVD, stroke, metabolic dysfunction, asthma, chronic obstructive pulmonary d…

…y (AATD) is a rare genetic disorder associated with early-onset chronic obstructive pulmonary disease and impaired quality of life (QoL). This retrospective study ev…

…Asthma and chronic obstructive pulmonary disease (COPD) are among the …

…cle mass (sarcopenia) are known predictors of poor prognosis in chronic obstructive pulmonary disease (COPD). Isolated muscle weakness (dynapenia) or low muscle mass…

…abilitation (PR) is an effective intervention for patients with chronic obstructive pulmonary disease (COPD) but impact typically only lasts 6–12 months. This paper …

… 1.76), smoking-related cancer (aHR 1.42, 95% CI 1.33 to 1.52), peripheral vascular disease (aHR 1.42, 95% CI 1.35 to 1.49), admission to critical care (aH…